OXALIPLATIN KABI

5MG/ML INF CNC SOL 1X20ML

SÚKL code 0128133
Name of the product OXALIPLATIN KABI 5 MG/ML KONCENTRÁT PRO INFUZNÍ ROZTOK
_MA_MEDICATION_DETAIL_INFO_MED_NAME i OXALIPLATIN KABI
Supplement 5MG/ML INF CNC SOL 1X20ML
Strenght 5MG/ML
Pharmaceutical form Concentrate for solution for infusion
Package 1X20ML
Route Intravenous use
Language of the pack Czech
Wrap type Vial
Legal status na lékařský předpis
Active substance OXALIPLATIN (OXALIPLATINUM)
ATC group L01XA03
ATC group name OXALIPLATINA

Marketing authorisation information

Registration Number 44/ 624/09-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 06. 2019
MA Holder Fresenius Kabi Oncology Plc., Bordon,Hampshire
MA Holder country VELKÁ BRITÁNIE
Actual MA holder Fresenius Kabi s.r.o., Praha
Actual MA holder country ČESKÁ REPUBLIKA

Back to list